Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AL

ALNY

Market Closed

Alnylam Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnology
US
2.50K employees
CEO: Yvonne L. Greenstreet
Founded: 2004
$216.12
+$0.00(+NaN%)
Market Cap
28.92B
Beta
0.27
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Overall Sentiment
30%
Negative
Based on 1 of 3 sources
News
30%
Social
--
Analyst
--
News Media
Overall Score30%
Positive Articles3
Neutral Articles0
Negative Articles7
Total Coverage10 articles
Social Media
No social media data available
Wall Street Analysts
No analyst recommendation data available
Social Sentiment & Market Signals
Real-time social media buzz and conversation analysis

No social sentiment data available

Social media conversation data will appear here once loaded

News Sentiment Risk Analysis
Market sentiment and news coverage impact assessment
Total Articles
10
Avg Sentiment
-0.328

Negative

Positive News
30.0%
Negative News
70.0%

Sentiment Distribution & Risk Assessment

Coverage:Low
Trend:Negative
Positive
30.0%
Neutral
0.0%
Negative
70.0%
NEGATIVEBased on 10 articles

Recent Headlines Impact

No recent news headlines available
Analyst Recommendations
Wall Street analyst consensus and rating distribution

No Analyst Data Available

Analyst recommendations are not available for this stock

Explore ALNY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ALNY in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →